BackCodiak Biosciences Overview

Codiak Biosciences Intangible Assets

Track Codiak Biosciences's intangible assets ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00

Peer average

Loading

Codiak Biosciences Intangible Assets History

Loading

Codiak Biosciences vs. peers: Intangible Assets Comparison

Loading

Codiak Biosciences Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Codiak Biosciences (CDAK) FAQ

Codiak Biosciences (CDAK) currently reports a intangible assets of $0 as of September 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Codiak Biosciences's intangible assets history and peer comparisons.

Codiak Biosciences's intangible assets changed from $0 to $0 (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Codiak Biosciences reported $0 in intangible assets as of September 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Codiak Biosciences, and consider following CDAK for alerts when major investors trade the stock.

Codiak Biosciences is classified in the Healthcare sector. On intangible assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CDAK with unrelated industries.